ARYLSULFONAMIDE-BASED MATRIX METALLOPROTEASE INHIBITORS
The present invention provides a compound of formula (I): said compound is inhibitor of MMP-2, and/or MMP-8, and/or MMP-9, and/or MMP-12 and/or MMP-13, and thus can be employed for the treatment of a disorder or disease characterized by abnormal activity of MMP-2, and/or MMP-8, and/or MMP-9, and/or...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; pol |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | MCQUIRE, LESLIE WIGHTON SHULTZ, MICHAEL RIGOLLIER, PASCAL ROGEL, OLIVIER EHRHARDT, CLAUS TOMMASI, RUBEN ALBERTO |
| description | The present invention provides a compound of formula (I): said compound is inhibitor of MMP-2, and/or MMP-8, and/or MMP-9, and/or MMP-12 and/or MMP-13, and thus can be employed for the treatment of a disorder or disease characterized by abnormal activity of MMP-2, and/or MMP-8, and/or MMP-9, and/or MMP-12 and/or MMP-13. Accordingly, the compound of formula (I) can be used in treatment of disorders or diseases mediated by MMP-2, and/or MMP-8, and/or MMP-9, and/or MMP-12, and/or MMP-13. Finally, the present invention also provides a pharmaceutical composition. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_PL2268612TT3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>PL2268612TT3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_PL2268612TT33</originalsourceid><addsrcrecordid>eNrjZDB3DIr0CQ71cfP3c_T1dHHVdXIMdnVR8HUMCfKMUPB1DXH08fEPCPIPcQWKK3j6eXg6eYb4BwXzMLCmJeYUp_JCaW4GRTfXEGcP3dSC_PjU4oLE5NS81JL4AB8jIzMLM0OjkBBjY2LUAACGOCk6</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ARYLSULFONAMIDE-BASED MATRIX METALLOPROTEASE INHIBITORS</title><source>esp@cenet</source><creator>MCQUIRE, LESLIE WIGHTON ; SHULTZ, MICHAEL ; RIGOLLIER, PASCAL ; ROGEL, OLIVIER ; EHRHARDT, CLAUS ; TOMMASI, RUBEN ALBERTO</creator><creatorcontrib>MCQUIRE, LESLIE WIGHTON ; SHULTZ, MICHAEL ; RIGOLLIER, PASCAL ; ROGEL, OLIVIER ; EHRHARDT, CLAUS ; TOMMASI, RUBEN ALBERTO</creatorcontrib><description>The present invention provides a compound of formula (I): said compound is inhibitor of MMP-2, and/or MMP-8, and/or MMP-9, and/or MMP-12 and/or MMP-13, and thus can be employed for the treatment of a disorder or disease characterized by abnormal activity of MMP-2, and/or MMP-8, and/or MMP-9, and/or MMP-12 and/or MMP-13. Accordingly, the compound of formula (I) can be used in treatment of disorders or diseases mediated by MMP-2, and/or MMP-8, and/or MMP-9, and/or MMP-12, and/or MMP-13. Finally, the present invention also provides a pharmaceutical composition.</description><language>eng ; pol</language><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS ; CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2015</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20150227&DB=EPODOC&CC=PL&NR=2268612T3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25546,76297</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20150227&DB=EPODOC&CC=PL&NR=2268612T3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MCQUIRE, LESLIE WIGHTON</creatorcontrib><creatorcontrib>SHULTZ, MICHAEL</creatorcontrib><creatorcontrib>RIGOLLIER, PASCAL</creatorcontrib><creatorcontrib>ROGEL, OLIVIER</creatorcontrib><creatorcontrib>EHRHARDT, CLAUS</creatorcontrib><creatorcontrib>TOMMASI, RUBEN ALBERTO</creatorcontrib><title>ARYLSULFONAMIDE-BASED MATRIX METALLOPROTEASE INHIBITORS</title><description>The present invention provides a compound of formula (I): said compound is inhibitor of MMP-2, and/or MMP-8, and/or MMP-9, and/or MMP-12 and/or MMP-13, and thus can be employed for the treatment of a disorder or disease characterized by abnormal activity of MMP-2, and/or MMP-8, and/or MMP-9, and/or MMP-12 and/or MMP-13. Accordingly, the compound of formula (I) can be used in treatment of disorders or diseases mediated by MMP-2, and/or MMP-8, and/or MMP-9, and/or MMP-12, and/or MMP-13. Finally, the present invention also provides a pharmaceutical composition.</description><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS</subject><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2015</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDB3DIr0CQ71cfP3c_T1dHHVdXIMdnVR8HUMCfKMUPB1DXH08fEPCPIPcQWKK3j6eXg6eYb4BwXzMLCmJeYUp_JCaW4GRTfXEGcP3dSC_PjU4oLE5NS81JL4AB8jIzMLM0OjkBBjY2LUAACGOCk6</recordid><startdate>20150227</startdate><enddate>20150227</enddate><creator>MCQUIRE, LESLIE WIGHTON</creator><creator>SHULTZ, MICHAEL</creator><creator>RIGOLLIER, PASCAL</creator><creator>ROGEL, OLIVIER</creator><creator>EHRHARDT, CLAUS</creator><creator>TOMMASI, RUBEN ALBERTO</creator><scope>EVB</scope></search><sort><creationdate>20150227</creationdate><title>ARYLSULFONAMIDE-BASED MATRIX METALLOPROTEASE INHIBITORS</title><author>MCQUIRE, LESLIE WIGHTON ; SHULTZ, MICHAEL ; RIGOLLIER, PASCAL ; ROGEL, OLIVIER ; EHRHARDT, CLAUS ; TOMMASI, RUBEN ALBERTO</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_PL2268612TT33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; pol</language><creationdate>2015</creationdate><topic>ACYCLIC OR CARBOCYCLIC COMPOUNDS</topic><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>MCQUIRE, LESLIE WIGHTON</creatorcontrib><creatorcontrib>SHULTZ, MICHAEL</creatorcontrib><creatorcontrib>RIGOLLIER, PASCAL</creatorcontrib><creatorcontrib>ROGEL, OLIVIER</creatorcontrib><creatorcontrib>EHRHARDT, CLAUS</creatorcontrib><creatorcontrib>TOMMASI, RUBEN ALBERTO</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MCQUIRE, LESLIE WIGHTON</au><au>SHULTZ, MICHAEL</au><au>RIGOLLIER, PASCAL</au><au>ROGEL, OLIVIER</au><au>EHRHARDT, CLAUS</au><au>TOMMASI, RUBEN ALBERTO</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ARYLSULFONAMIDE-BASED MATRIX METALLOPROTEASE INHIBITORS</title><date>2015-02-27</date><risdate>2015</risdate><abstract>The present invention provides a compound of formula (I): said compound is inhibitor of MMP-2, and/or MMP-8, and/or MMP-9, and/or MMP-12 and/or MMP-13, and thus can be employed for the treatment of a disorder or disease characterized by abnormal activity of MMP-2, and/or MMP-8, and/or MMP-9, and/or MMP-12 and/or MMP-13. Accordingly, the compound of formula (I) can be used in treatment of disorders or diseases mediated by MMP-2, and/or MMP-8, and/or MMP-9, and/or MMP-12, and/or MMP-13. Finally, the present invention also provides a pharmaceutical composition.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; pol |
| recordid | cdi_epo_espacenet_PL2268612TT3 |
| source | esp@cenet |
| subjects | ACYCLIC OR CARBOCYCLIC COMPOUNDS CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | ARYLSULFONAMIDE-BASED MATRIX METALLOPROTEASE INHIBITORS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T08%3A57%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MCQUIRE,%20LESLIE%20WIGHTON&rft.date=2015-02-27&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EPL2268612TT3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |